Comparing the efficacy and safety of rituximab with other biosimilars combined with CHOP regimen in the treatment of patients with newly diagnosed diffuse large B-cell lymphoma

FAN Dandan; HU Maogui; DING Kaiyang; CAO Linlin; FENG Yuanyuan; WANG Cuicui; MING Jing; SONG Hao; WANG Xinchen

doi:10.3969/j.issn.1006-5725.2023.08.018

Home>Articles>Comparing the efficacy and safety of rituximab with other biosimilars combined with CHOP regimen in the treatment of patients with newly diagnosed diffuse large B-cell lymphoma

DOI: 10.3969/j.issn.1006-5725.2023.08.018

Comparing the efficacy and safety of rituximab with other biosimilars combined with CHOP regimen in the treatment of patients with newly diagnosed diffuse large B-cell lymphoma

FAN Dandan

HU Maogui

DING Kaiyang

CAO Linlin

FENG Yuanyuan

WANG Cuicui

MING Jing

SONG Hao

WANG Xinchen

Machine-generated Keywords：

Publication Date：2023-04-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：7( 1022-1028 )

The Journal of Practical Medicine

ISTICPKU

ISSN：1006-5725

Year, Vol.(Issue)：2023,39(8)